WallStSmart

Churchill Capital Corp XI (CCXI)vsRF Acquisition Corp III Ordinary Shares (RFAM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

RFAM leads profitability with a 0.0% profit margin vs 0.0%. CCXI earns a higher WallStSmart Score of 24/100 (F).

CCXI

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

RFAM

Avoid

20

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 5.8

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

RFAM0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$779.80M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

RFAM4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$137.94M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : RFAM

RFAM has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : RFAM

The primary concerns for RFAM are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

RFAM is growing revenue faster at 0.0% — sustainability is the question.

RFAM generates stronger free cash flow (-41,790), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCXI scores higher overall (24/100 vs 20/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

RF Acquisition Corp III Ordinary Shares

FINANCIAL SERVICES · SHELL COMPANIES · USA

RF Acquisition Corp III focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company is headquartered in Singapore.

Want to dig deeper into these stocks?